AI Won't Kill CROs, Says Industry
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Despite recent drops in CRO stocks, investors fears of AI replacing clinical trials are unfounded. CROs offer irreplaceable services like global trial site networks, patient recruitment, and real-world execution. While AI may streamline tasks, human oversight remains crucial for safety and regulatory compliance. Wall Street views this as a temporary panic, with smart CROs potentially leveraging AI for faster trials and new revenue streams.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/c743b10e6c460e22